IL-18 has been correlated with pulmonary function in COPD patients [37] and, in an IL-18 transgenic mouse model, was identified as key driver regulating downstream responses including mucus metaplasia, airway fibrosis, and vascular remodeling [38]. The gene discussed is IL18; the disease is chronic obstructive pulmonary disease.